Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2005-06-07
2009-08-11
Canella, Karen A (Department: 1642)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387300, C530S387700, C530S388100, C530S388220, C530S388800, C530S808000, C530S809000, C536S023530, C435S070100, C435S070200, C435S070210
Reexamination Certificate
active
07572895
ABSTRACT:
The invention provides further characterization of the disease and cancer-associated antigen, transferrin receptor. The invention also provides a novel family of antibodies that bind to the transferrin receptor, methods of diagnosing and treating various human cancers and diseases that express transferrin receptor.
REFERENCES:
patent: 3842067 (1974-10-01), Sarantakis
patent: 3862925 (1975-01-01), Sarantakis et al.
patent: 3972859 (1976-08-01), Fujino et al.
patent: 4105603 (1978-08-01), Vale, Jr. et al.
patent: RE30548 (1981-03-01), Vale, Jr. et al.
patent: 4434156 (1984-02-01), Trowbridge
patent: 4676980 (1987-06-01), Segal et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 5552391 (1996-09-01), Coutts et al.
patent: 5565332 (1996-10-01), Hoogenboom et al.
patent: 5580717 (1996-12-01), Dower et al.
patent: 5656444 (1997-08-01), Webb et al.
patent: 5733743 (1998-03-01), Johnson et al.
patent: 5807715 (1998-09-01), Morrison et al.
patent: 5866692 (1999-02-01), Shitara et al.
patent: 5997867 (1999-12-01), Waldmann et al.
patent: 6054297 (2000-04-01), Carter et al.
patent: 6054561 (2000-04-01), Ring
patent: 6180377 (2001-01-01), Morgan et al.
patent: 6265150 (2001-07-01), Terstappen et al.
patent: 6331415 (2001-12-01), Cabilly et al.
patent: 6441163 (2002-08-01), Chari et al.
patent: 6541225 (2003-04-01), Li
patent: 2003/0109006 (2003-06-01), Li
patent: 2004/0180002 (2004-09-01), Young et al.
patent: 2004/0197328 (2004-10-01), Young et al.
patent: 2004/0258693 (2004-12-01), Young et al.
patent: 0 519 596 (1992-12-01), None
patent: 0 519 596 (1992-12-01), None
patent: WO-01/43869 (2001-06-01), None
patent: WO-01/43869 (2001-06-01), None
patent: WO-01/55216 (2001-08-01), None
patent: WO-2005/121179 (2005-12-01), None
Bowie et al (Science, 1990, 257:1306-1310).
Rudikoff et al, (PNAS, USA, 1982, 79: 1979-1983).
Burgess et al (J of Cell Bio. 111:2129-2138, 1990).
Coleman et al. (Research in Immunology, 1994; 145(1): 33-36).
Abaza et al. (Journal of Protein Chemistry, vol. 11, No. 5, 1992, pp. 433-444).
Janeway et al. (Immunobiology 5, 2001, p. 100-101).
Gussow et al. (1991, Methods in Enzymology 203:99-121).
MacCallum et al. (J. Mol. Biol. (1996) 262, 732-745).
Casset et al. (BBRC 2003 307:198-205).
Wu et al. (J. Mol. Biol. (1999) 294, 151-162).
Fristrom and Clegg (Principles of Genetics, 2nd ed., New York, 1988, p. 775).
The American Heritage Dictionary of the English Language, 4th Ed., 2000, online.
Aruffo, A. et al. (Dec. 1987). “Molecular Cloning of a CD28 cDNA by a High-Efficiency COS Cell Expression System,”Proc. Natl. Acad. Sci. USA84:8573-8577.
Bird, R.E. et al. (Oct. 21, 1988). “Single-Chain Antigen-Binding Proteins,”Science242(4877):423-426.
Brooks, D. et al. (Nov. 1995). “Phase la Trial of Murine Immunoglobulin A Antitransferrin Receptor Antibody 42/6,”Clin. Cancer Res.1:1259-1265.
Brown, B.A. et al. (Jul. 1, 1987). “Tumor-Specific Genetically Engineered Murine/Human Chimeric Monoclonal Antibody,”Cancer. Res.47:3577-3583.
Carter, P. et al. (May 1992). “Humanization of an Anti-p185HER2Antibody for Human Cancer Therapy,”Proc. Natl. Acad. Sci. USA89:4285-4289.
Co, M.S. et al. (Apr. 1991). “Humanized Antibodies for Antiviral Therapy,”Proc. Natl. Acad. Sci. USA88:2869-2873.
Co, M.S. et al. (Feb. 15, 1992). “Chimeric and Humanized Antibodies With Specificity for the CD33 Antigen,”J. Immunol.148(4):1149-1154.
Daugherty, B.L. et al. (1991). “Polymerase Chain Reaction Facilitates the Cloning, CDR-Grafting, and Rapid Expression of a Murine Monoclonal Antibody Directed Against the CD18 Component of Leukocyte Integrins,”Nucl. Acids. Res.19(9):2471-2476.
Dean, P.D.G. et al. eds. (1985).Affinity Chromatography: A Practical Approach, IRL Press, pp. viii-xiv (Table of Contents Only.).
Dillman, R.O. et al. (Nov. 1, 1988). “Superiority of an Acid-Labile Daunorubicin-Monoclonal Antibody Immunoconjugate Compared to Free Drug,”Cancer Res.48:6097-6102.
Gatter, K.C. et al. (1983). “Transferrin Receptors in Human Tissues: Their Distribution and Possible Clinical Relevance,”J. Clin. Pathol.36:539-545.
Goldenberg, D.M. ed. (1995),Cancer Therapy with Radiolabeled Antibodies, CRC Press: Boca Raton, FL, 4 pages (Table of Contents Only.).
Gorman, S.D. et al. (May 1991). “Reshaping a Therapeutic CD4 Antibody,”Proc. Natl. Acad. Sci. USA88:4181-4185.
Griffin, T.W. et al. (1992). “Combined Antitumor Therapy with the Chemotherapeutic Drug Doxorubicin and an Anti-Transferrin Receptor Immunotoxin: In vitro and in vivo Studies,”J. Immunol.11:12-18.
Gross, S. et al. (1997). “Characterization and Phenotypic Analysis of Differentiating CD34+ Human Bone Marrow Cells in Liquid Culture,”Eur. J. Haematol.59:318-326.
Houghten, R.A. (Aug. 1985). “General Method for the Rapid Solid-Phase Synthesis of Large Numbers of Peptides: Specificity of Antigen-Antibody Interaction at the Level of Individual Amino Acids,”Proc. Natl. Acad. Sci. USA82:5131-5135.
Jefferies, W.A. et al. (Nov. 8, 1984). “Transferrin Receptor on Endothelium of Brain Capillaries,”Nature312:162-163.
Jones, P.T. et al. (May 29, 1986). “Replacing the Complementarity-Determining Regions in a Human Antibody with Those from a Mouse,”Nature321:522-525.
Kane, S. et al. (Jun. 21, 2002). “A Method to identify Serine Kinase Substrates,”J. Bio. Chem.277(25):22115-22118.
Kelley, R. F. et al. (1990). “Folding of Eukaryotic Proteins Produced inEscherichia coli”InGenetic Engineering: Principles and Methods, vol. 12, Setlow, J.K. et al. eds. Plenum Press: New York, NY, 88:1-19.
Kemp, J.D. (1997). “Iron Deprivation and Cancer: A View Beginning with Studies of Monoclonal Antibodies Against the Transferrin Receptor,”Histol. Histopathol.12:291-296.
Kettleborough, C.A. et al. (1991). “Humanization of a Mouse Monoclonal Antibody by CDR-Grafting: The Importance of Framework Residues on Loop Conformation,”Protein Engineering4(7): 773-783.
Kohler, G. et al. (Aug. 7, 1975). “Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity,”Nature256:495-497.
LoBuglio, A.F. et al. (Jun 1989). “Mouse/Human Chimeric Monoclonal Antibody in Man: Kinetics and Immune Response,”Proc. Natl. Acad. Sci. USA86:4220-4224.
Lonberg, N. et al. (1995). “Human Antibodies from Transgenic Mice,”Int. Rev. Immunol.13:65-93.
Lowe, C.R. (1979). “An Introduction to Affinity Chromatography” InLaboratory Techniques in Biochemistry and Molecular Biology; Work, T.S. et al. eds. North-Holland Publishing Company, vol. 7, Part II, pp. 269-273 (Table of Contents Only).
Maeda, H. et al. (Jul. 1991). “Construction of Reshaped Human Antibodies with HIV-Neutralizing Activity,”Human Antibodies Hybridoma2:124-134.
Mahato, R.I. et al. (1997). “Cationic Lipid-Based Gene Delivery Systems: Pharmaceutical Perspectives,”Pharm. Res.14(7):853-859.
Mangham, D.C. et al. (1999). “A Novel Immunohistochemical Detection System Using Mirror Image Complementary Antibodies (MICA),”Histopathology35(2):129-133.
Merrifield, R.B. (Jul. 20, 1963). “Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide,”J. Am. Chem Soc.85:2149-2154.
Neckers, L.M. et al. (Jun. 1983). “Transferrin Receptor Induction in Mitogen-Stimulated Human T Lymphocytes is Required for DNA Synthesis and Cell Division and is Regulated by Interleukin 2,”Proc. Natl. Acad. Sci. USA80:3494-3498.
Orte, C. et al. (1999). “A Comparison of Blood-Brain Barrier and Blood-Nerve Barrier Endothelial Cell Markers,”Anat. Embryol.199:509-517.
Peeters, K. et al. (2001). “Production of Antibodies and Antibody Fragments in Plants,”Vaccine19:2756-2761.
Pollock, D.P. et al. (1999). “Transgenic Milk as a Method for the Production of Recombinant Antibodies,”J. Immunol. Methods231:147-157.
Porath, J. et al. (1975). “
Li Rong-hao
Mather Jennie P.
Roberts Penelope E.
Canella Karen A
Morrison & Foerster / LLP
Raven Biotechnologies, Inc.
Reddig Peter J
LandOfFree
Transferrin receptor antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transferrin receptor antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transferrin receptor antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4067563